Spots Global Cancer Trial Database for Using Aspirin to Improve Immunological Features of Ovarian Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Using Aspirin to Improve Immunological Features of Ovarian Tumors
Official Title: Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors
Study ID: NCT05080946
Study Description
Brief Summary: The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Moffitt Cancer Center, Tampa, Florida, United States
University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States
Inova Schar Cancer Institute, Fairfax, Virginia, United States
Contact Details
Name: Jing-Yi Chern, MD
Affiliation: Moffitt Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
